CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant.
Kang Y, Wu Z, Lau TC, Lu X, Liu L, Cheung AK, Tan Z, Ng J, Liang J, Wang H, Li S, Zheng B, Li B, Chen L, Chen Z.
Kang Y, et al. Among authors: chen z, chen l.
J Biol Chem. 2012 May 11;287(20):16499-509. doi: 10.1074/jbc.M112.354084. Epub 2012 Mar 23.
J Biol Chem. 2012.
PMID: 22447925
Free PMC article.